CONSTANTINE CANNON, LLP for AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
Foreign entity interest: Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN S ANDERSON | — |
| W STEPHEN CANNON | — |
| JOSEPH H GIBSON | — |
Pharmacy PHA
Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
Foreign entity interest: Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN S ANDERSON | — |
| W STEPHEN CANNON | — |
| JOSEPH H GIBSON | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Japan | Japan | 14.3% | $6,666 |
Affiliated organisations
| Organisation | Location |
|---|---|
| MILLENNIUM:THE TAKEDA ONCOLOGY CO | Cambridge, MA, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.